Olodaterol
| Evidence Level: N/A | Predicted Indications: 0 |
Table of Contents
Olodaterol
Quick Overview
| Item | Content |
|---|---|
| Original Indication | Not recorded in the local data |
| Australia Market Status | Listed on the PBS Schedule (2 of 2 items) – TGA (ARTG) registration status is not included in this data |
| Number of PBS Items | 2 (valid: 2) |
Australia Market Information
| ARTG Number | Product Name | Dosage Form |
|---|---|---|
| ARTG 14849M | Spiolto Respimat | Inhalation solution (tiotropium 2.5 µg + olodaterol 2.5 µg per dose), 60 doses, pack of 2 |
| ARTG 10557P | Spiolto Respimat | Inhalation solution (tiotropium 2.5 µg + olodaterol 2.5 µg per dose), 60 doses |
Safety Considerations
- Drug Interactions: 326 interactions were identified in the interaction database, and all of those listed are rated Moderate. Examples include:
- Sympathomimetics: epinephrine (including topical and ophthalmic forms), ephedrine, isometheptene, phentermine, diethylpropion, fenfluramine
- QT-relevant agents: clarithromycin, cisapride, dolasetron, granisetron, palonosetron
- Other agents: famotidine, loperamide, canagliflozin, ertugliflozin, semaglutide, albiglutide
A full medication review is advisable before use. Please refer to the TGA-approved Product Information (PI) for warnings and contraindications.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.